We generated adjusted EBITDA before COVID-19 expenses of $374.8 million in fiscal 2020, an increase of $72.3 million or 23.9%.
Adjusted EBITDA as a percentage of net sales was 18.2% in fiscal 2019.
We reported net sales of $1.968 billion in fiscal 2020, an increase of $307.5 million or 18.5% compared to the prior year.
Adjusted EBITDA before COVID-19 expenses as a percentage of net sales was 19% in fiscal 2020.
